Antibodies required for therapeutic use will be required to be structurally indistinct to other endogenous circulating human antibodies, to minimize immunogenicity following their introduction into the patient.
A simple “copy-and-paste” approach to introduce a rodent CDR into a human antibody scaffold will often diminish or destroy the binding specificity and affinity of the original rodent antibody. Humanization therefore will rely on discrete CDR residue substitutions to obtain an optimum balance of minimal immunogenicity toward the antibody, while maintaining the original binding and recognition characteristics.
ProMab can humanize your already established mouse monoclonal antibody or start from scratch if you are interested in antibody humanization.
Fully Humanized Mouse Models
Fully humanized mice models have been established for therapeutic, fully human mAb discovery.
The fully humanized mice model showed strong and desirable immune response upon challenging of several therapeutic antigens.
The fully humanized mice model expresses antibodies from inserted human heavy VDJ and kappa VJ segments and showed desirable diversity.
The mice can be used to efficiently generate high quality full human mAb via hybridoma technology.
Inquire today for an introduction about this innovative technology.